Spontaneous bacterial peritonitis (SBP) is a severe, life-threatening infection of ascitic fluid that occurs in the absence of any primary, surgically treatable intra-abdominal source of infection, most frequently complicating decompensated cirrhosis accompanied by portal hypertension1,2. As one of the most common and perilous bacterial infections in hepatology, SBP carries significant mortality rates ranging from 20% to 40% during initial presentation if therapy is delayed, necessitating prompt recognition, rigorous diagnostic paracentesis, and immediate empiric antimicrobial and colloid resuscitation3,4.

1. Etiology & Risk Factors

  • Primary Pathogenic Organisms: Historically dominated by enteric Gram-negative bacilli, particularly Escherichia coli (accounting for 40-50% of cases) and Klebsiella pneumoniae4,7. However, Gram-positive organisms such as Streptococcus pneumoniae, Enterococcus species, and staphylococci account for an increasing proportion of nosocomial and healthcare-associated episodes4,6.
  • Low Ascitic Fluid Total Protein: Patients with an ascitic fluid total protein concentration below 1.5 g/dL exhibit markedly reduced opsonic activity and complement levels, representing a primary intrinsic risk factor for bacterial colonization and proliferation6,7.
  • Prior History of SBP: A previous episode of SBP confers a high recurrence rate (exceeding 70% within one year), mandating lifelong secondary antibiotic prophylaxis unless liver transplantation is successfully performed6.
  • Gastrointestinal Hemorrhage: Acute variceal or non-variceal upper GI bleeding precipitates mucosal hypoperfusion and bacterial translocation, serving as an acute trigger that mandates short-term prophylactic antibiotic therapy4,7.
  • Advanced Liver Disease Severity: High Model for End-Stage Liver Disease (MELD) scores, Child-Pugh Class C status, low serum sodium (<130 mEq/L), and severe hyperbilirubinemia correlate strongly with depressed systemic and local immune defenses2,3.

2. Pathophysiology

The pathogenesis of spontaneous bacterial peritonitis hinges on three interdependent pathophysiological aberrations: intestinal bacterial overgrowth, heightened mucosal permeability, and systemic and local immune defects characteristic of advanced cirrhosis2,7. Portal hypertension induces mucosal edema and splanchnic congestion, facilitating the transmigration of viable enteric bacteria across the intestinal barrier into the mesenteric lymph nodes and subsequently into the peritoneal cavity4,7. In healthy individuals, ascitic fluid contains adequate concentrations of complement proteins (e.g., C3) and opsonins capable of clearing translocated bacteria; however, synthetic dysfunction of the cirrhotic liver leads to profound complement deficiency within the ascetic fluid2,7. Once bacteria establish residency within the protein-poor peritoneal environment, unchecked proliferation triggers a vigorous local inflammatory response characterized by neutrophil recruitment, release of pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6), systemic vasodilation, and worsening circulatory dysfunction that culminates in renal hypoperfusion and hepatorenal syndrome2,3.

Spontaneous bacterial peritonitis — Pathophysiological Cascade & Clinical Flowchart 1 Trigger / Primary Insult Intestinal bacterial overgrowth and increased gut mucosal permeability in decompensated cirrhosis 2 Cellular / Pathophysiological Cascade Bacterial translocation across the intestinal wall into mesenteric lymph nodes and sterile ascitic fluid 3 Target Organ / Structural Change Deficient local opsonins, low complement levels, and impaired reticuloendothelial function in ascitic fluid 4 Hallmark Clinical & Diagnostic Manifestation Ascitic fluid PMN count ≥250/mm³ accompanied by fever, worsening abdominal pain, or acute encephalopathy 5 Complications if Untreated & Therapeutic Target Progression to septic shock, multi-organ failure, and hepatorenal syndrome; averted by prompt empiric antibiotics and volume expansion

3. Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: The clinical presentation is frequently insidious. While classic manifestations include fever, chills, and diffuse or localized abdominal tenderness, up to 30% of patients may present asymptomatically or with subtle clinical clues3,4. Common presenting complaints comprise worsening ascites refractory to diuretics, altered mental status (hepatic encephalopathy), unexplained renal impairment, malaise, and ileus3,4.
  • Physical Examination & Named Clinical Signs: Examination often reveals diffuse abdominal guarding, rebound tenderness (though frequently less pronounced than in secondary bacterial peritonitis due to the underlying tense ascites), diminished or absent bowel sounds, shifting dullness, and stigmata of chronic liver disease (spider angiomata, palmar erythema, jaundice, caput medusae, and asterixis)3,4.

4. Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationDiagnostic Abdominal Paracentesis demonstrating an Ascitic Fluid Absolute Polymorphonuclear (PMN / Neutrophil) count ≥250 cells/mm³ (≥0.25 × 10⁹/L) in the absence of an intra-abdominal surgical source2,4.
Laboratory PanelAscitic fluid total protein <1.5 g/dL, glucose >50 mg/dL, LDH normal or mildly elevated, and serum-ascites albumin gradient (SAAG) ≥1.1 g/dL indicating portal hypertension. Blood cultures, urine cultures, and complete metabolic panel showing acute kidney injury (rising creatinine).
Imaging / Radiology (X-ray, US, CT, MRI)Abdominal ultrasound to evaluate liver parenchymal echotexture, detect portal vein thrombosis, assess splenomegaly, and safely guide paracentesis to avoid visceral or vascular injury4. Computed tomography (CT) with contrast is reserved to rule out secondary peritonitis if free air or a focal intra-abdominal abscess is suspected.
ECG / Histopathology / ProceduralBedside inoculation of ascitic fluid directly into aerobic and anaerobic blood culture bottles at the bedside increases microbial recovery sensitivity up to 80% compared to traditional agar plates6. Gram stain has low sensitivity (~50%) but aids in identifying Gram-positive cocci or mixed flora.

5. Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Ascitic Fluid PMN Count Stratification<250 cells/mm³ with negative culture: Non-infected ascites (monitor); <250 cells/mm³ with positive culture: Bacterascites (repeat paracentesis if clinical signs present, treat if symptomatic); ≥250 cells/mm³: Spontaneous bacterial peritonitis (immediate empiric antimicrobial therapy indicated)2,6.
Differentiation from Secondary PeritonitisSecondary peritonitis suggested by multiple organisms on Gram stain/culture, ascitic fluid total protein >1.0 g/dL, glucose <50 mg/dL, and LDH greater than serum upper limit of normal (or multiple criteria met: protein >1 g/dL, glucose <50 mg/dL, LDH > upper limit of normal). Requires urgent surgical evaluation and broad-spectrum coverage3,5.
MELD Score & Prognostic StratificationModel for End-Stage Liver Disease (MELD) score incorporating bilirubin, INR, and creatinine. Higher MELD scores (>18) correlate with markedly increased inpatient mortality and warrant expedited liver transplantation evaluation alongside aggressive SBP management2,3.

6. Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Secondary Bacterial PeritonitisCaused by hollow viscus perforation (e.g., peptic ulcer, diverticulitis). Characterized by multiple organisms on culture, high protein (>1.0 g/dL), low glucose (<50 mg/dL), elevated LDH, and free intraperitoneal air on CT imaging. Requires surgical intervention3,5.
Tuberculous PeritonitisIndolent presentation with low-grade fever, weight loss, and doughy abdomen. Ascitic fluid demonstrates lymphocytic predominance (>70% lymphocytes), high ADA (adenosine deaminase >40 U/L), elevated protein (>2.5 g/dL), and positive AFB stain or PCR testing5.
Spontaneous BacterascitesColonization of ascitic fluid without significant local inflammatory reaction (PMN <250 cells/mm³). Patients may be asymptomatic or develop SBP; requires repeat paracentesis and close observation or treatment if systemic symptoms develop2,6.
Portal Vein Thrombosis / Hepatic InfarctionAcute abdominal pain and worsening ascites in cirrhosis. Doppler ultrasound demonstrates absent flow or thrombus within the portal venous system without elevated ascitic fluid PMN count3,4.

7. Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Immediate hemodynamic monitoring, placement of large-bore peripheral intravenous lines, continuous pulse oximetry, and correction of electrolyte imbalances or coagulopathies. Routine prophylactic antibiotics should be administered prior to paracentesis if clinical suspicion is extremely high and procedural delay is anticipated2,4.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing):
    • Empiric Antimicrobial Therapy: Intravenous third-generation cephalosporins represent the gold standard. Regimens include Cefotaxime 2 g IV every 8 hours or Ceftriaxone 2 g IV every 24 hours for a standard duration of 5 days2,6. In nosocomial settings or centers with high multi-drug resistant organism prevalence, broader coverage with carbapenems or piperacillin-tazobactam plus glycopeptides may be tailored per local antibiograms3,4.
    • Intravenous Albumin Resuscitation: To prevent hepatorenal syndrome and reduce mortality in high-risk patients (defined by serum creatinine >1 mg/dL, BUN >30 mg/dL, or total bilirubin >4 mg/dL), administer IV Albumin at 1.5 g/kg on Day 1 followed by 1.0 g/kg on Day 32,3.
  • Surgical / Interventional Indications: Urgent exploratory laparotomy or surgical consultation is indicated only if secondary bacterial peritonitis is diagnosed or strongly suspected based on biochemical criteria and imaging demonstrating hollow viscus perforation or abscess formation3,5. Therapeutic paracentesis is reserved for tense ascites causing severe respiratory compromise or abdominal compartment physiology4.

8. Complications & Prognosis

  • Acute Kidney Injury and Hepatorenal Syndrome (HRS): Functional renal failure occurs in up to 30-40% of untreated or delayed SBP cases due to severe systemic vasodilation and activation of the renin-angiotensin-aldosterone system, contributing significantly to mortality2,3.
  • Septic Shock and Multi-Organ Failure: Uncontrolled bacteremia and systemic inflammatory response syndrome (SIRS) can rapidly progress to refractory hypotension, encephalopathy, and coagulopathy3,4.
  • Prognosis & Recurrence: In-hospital mortality has declined to approximately 10-20% with early administration of third-generation cephalosporins and albumin; however, the 1-year mortality rate remains high (40-70%) due to underlying advanced hepatic decompensation. Lifelong secondary antibiotic prophylaxis (e.g., Norfloxacin 400 mg daily or Ciprofloxacin 500 mg weekly) is mandatory following resolution of an index episode until liver transplantation is performed2,6.